Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis

Area of Science:

• Gastroenterology
• Molecular Biology
• Biomarker Discovery

Background:

• Inflammatory bowel disease (IBD) encompasses Crohn's disease (CD) and ulcerative colitis (UC).
• Accurate differentiation between Crohn's colitis (CC) and UC is crucial for treatment, especially surgical planning.
• Diagnostic ambiguity occurs in up to 15% of IBD cases confined to the colon.

Purpose of the Study:

• To investigate the potential of plasma microRNAs (miRNAs) as biomarkers for differentiating CC from UC.
• To identify specific miRNAs that are differentially expressed between CC and UC patients.

Main Methods:

• Plasma samples were collected from patients with isolated CC and UC.
• Screening of 380 common miRNAs was performed, followed by confirmation of differentially expressed miRNAs using single assays.
• A predictive model was developed and validated using blinded data to assess diagnostic accuracy.

Main Results:

• Seven miRNAs were initially selected for confirmation, with two miRNAs (miR-598 and miR-642) showing consistent differential expression (P = 0.013, P = 0.005).
• The predictive model utilizing these two miRNAs achieved an overall accuracy of 75% in differentiating CC from UC using blinded data.

Conclusions:

• Two plasma miRNAs, miR-598 and miR-642, were identified as potential biomarkers to distinguish CC from UC.
• The findings suggest the feasibility and promise of a plasma miRNA-based assay for differentiating these IBD subtypes.